The wearable defibrillator developer revealed GV is an existing investor as it raised more than $145m that will support the launch of its lead product.
Element Science, the US-based developer of a wearable cardiac monitor, secured $145.6m yesterday in a series C round that included GV, a corporate venturing vehicle for internet and technology group Alphabet.
Deerfield Healthcare and Qiming Venture Partners USA co-led the round, which also featured Cormorant Asset Management, Third Rock Ventures and Invus Opportunities.
Founded as Revive Defibrillation Systems, Element has created a wearable device called the Jewel Patch Wearable Cardioverter Defibrillator for cardiac patients transferring from the hospital to their…
